NCT01525147View on ClinicalTrials.gov

Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

November 30, 2013

Conditions
Rheumatic Arthritis
Interventions
BIOLOGICAL

YHB1411-2: Level 2

IV infusion

BIOLOGICAL

YHB1411-2: Level 3

IV infusion

BIOLOGICAL

YHB1411-2: Level 4

IV infusion

BIOLOGICAL

YHB1411-2: Level 5

IV infusion

BIOLOGICAL

Placebo

IV infusion

BIOLOGICAL

YHB1411-2: level 1

IV infusion

Trial Locations (1)

130-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01525147 - Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter